| 國立臺灣大學 |
1994 |
Fibrosing Cholestatic Hepatitis in a Hepatitis B Surface Antigen Carrier After Renal Transplantation
|
Chen, C. H.; Chen, P. J.; Chu, J. S.; Yeh, K. H.; Lai, M. Y.; 陳定信; Chen, C. H.; Chen, P. J.; Chu, J. S.; Yeh, K. H.; Lai, M. Y.; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T04:53:00Z |
Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation
|
Chen, C.-H. and Chen, P.-J. and Chu, J.-S. and Yeh, K.-H. and Lai, M.-Y. and Chen, D.-S.; PEI-JER CHEN; KUN-HUEI YEH; DING-SHINN CHEN |
| 臺大學術典藏 |
2021-01-28T01:07:03Z |
Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation
|
Chen C.-H.; Chen P.-J.; Chu J.-S.; KUN-HUEI YEH; Lai M.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:36:22Z |
Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation
|
Chen C.-H.; PEI-JER CHEN; Chu J.-S.; Yeh K.-H.; Lai M.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2022-02-22T05:34:47Z |
Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation
|
CHIEN-HUNG CHEN; Chen P.-J.; Chu J.-S.; Yeh K.-H.; Lai M.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2022-02-23T02:12:50Z |
Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation
|
CHIEN-HUNG CHEN; Chen P.-J.; Chu J.-S.; Yeh K.-H.; Lai M.-Y.; Chen D.-S. |
| 國立成功大學 |
2001-12 |
Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient
|
Shan, Yan-Shen; Lee, Po-Chang; Wang, Jen-Ren; Tsai, Huey-Pin; Sung, Chunne-Ming; Jin, Ying-Tai |
| 國立臺灣大學 |
2015 |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
|
Wang, Chia-Chi; Liu, Chen-Hua; Lin, Chih-Lin; Wang, Pin-Chao; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 臺大學術典藏 |
2021-05-24T07:20:36Z |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
|
Wang C.-C.; CHEN-HUA LIU; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:31Z |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
|
Wang C.-C.; Liu C.-H.; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:58Z |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
|
Chia-Chi Wang, Chen-Hua Liu, Chih-Lin Lin, Pin-Chao Wang, Tai-Chung Tseng, Hans Hsienhong Lin, Jia-Horng Kao; Wang, Chia-Chi;Liu, Chen-Hua;Lin, Chih-Lin;Wang, Pin-Chao;Tseng, Tai-Chung;Lin, Hans Hsienhong;Kao, Jia-Horng; Wang, Chia-Chi;Liu, Chen-Hua;Lin, Chih-Lin;Wang, Pin-Chao;Tseng, Tai-Chung;Lin, Hans Hsienhong;Kao, Jia-Horng; 劉振驊;高嘉宏; 劉振驊;高嘉宏; Wang, Chia-Chi; Hsu, Wan-Tseng; CHEN-HUA LIU; Liu, Chen-Hua; Shen, Li-Jiuan; JIA-HORNG KAO; Liu, Chen-Hua; Lee, Chii-Ming; Lin, Chih-Lin; Lin, Chih-Lin; Wang, Pin-Chao; Wang, Pin-Chao; Tseng, Tai-Chung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Lin, Hans Hsienhong; Kao, Jia-Horng; Kao, Jia-Horng; 李啟明; 沈麗娟 |
| 臺大學術典藏 |
2018-09-10T18:03:47Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng, T.-C. and Liu, C.-J. and Su, T.-H. and Yang, W.-T. and Chen, C.-L. and Yang, H.-C. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; TUNG-HUNG SU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-03-09T01:43:25Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:30Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:46Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:36Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:10:59Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:24Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C.; CHUN-JEN LIU; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:10Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:06Z |
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:21Z |
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection
|
Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:27Z |
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:38Z |
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:32Z |
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection
|
Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:17:07Z |
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
